GLP-1 Pills for Weight Loss
Wegovy tablets and Foundayo are the two FDA-approved GLP-1 pills for weight management. What the labels say, what each costs self-pay, and what to ask a prescriber.
The two approved pills
Wegovy tablets. The FDA label for Wegovy now covers both the weekly injection and a daily tablet. The tablet is indicated with a reduced-calorie diet and more physical activity to reduce excess body weight and maintain the reduction in adults with obesity, or with overweight plus at least one weight-related condition, and to reduce the risk of major cardiovascular events in adults with established cardiovascular disease and obesity or overweight.
Foundayo (orforglipron). Approved by the FDA on April 1, 2026 for chronic weight management in adults with obesity, or with overweight plus at least one weight-related condition, alongside diet and activity. It is a once-daily tablet from Eli Lilly.
Side by side
| Wegovy tablets | Foundayo | |
|---|---|---|
| Active ingredient | Semaglutide | Orforglipron |
| FDA action | Tablets added to the Wegovy label (December 2025) | New drug approval, April 1, 2026 |
| Dosing | Once daily, starting at 1.5 mg for 30 days, then stepped up every 30 days; 25 mg maintenance | Once daily, starting at 0.8 mg, then 2.5 mg and 5.5 mg after at least 30 days each; up to 9, 14.5 or 17.2 mg |
| How to take it | Empty stomach with up to 4 ounces of water, then wait 30 minutes before food, drinks or other oral medicines | Follow the label and your prescriber |
| Trial result in label or FDA notice | 13.6% average loss at 64 weeks vs 2.4% placebo (Study 7, label Table 10) | Statistically significant weight reduction vs placebo at 72 weeks in two trials (FDA notice) |
| Self-pay price (reviewed Nov 11, 2026) | $149 to $299 a month by dose | $149 to $299 a month by dose |
There is no head-to-head trial of the two pills, so the trial figures above are not a comparison. They come from separate studies with different designs.
Safety basics
- Both carry a boxed warning for thyroid C-cell tumors seen in rodents. Neither is for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Common side effects are digestive: nausea, diarrhea, vomiting, constipation and abdominal pain.
- Neither should be combined with another GLP-1 receptor agonist.
- Pregnancy: the Wegovy label says the medicine may cause fetal harm and advises stopping when pregnancy is recognized.
Next steps
A prescription is required. See how to get a GLP-1 prescription, compare self-pay costs, or find a provider on the GLP-1 near me page. Our listings cannot tell which products a clinic stocks, so ask whether it prescribes the pill you want.
Frequently asked questions
Is there a GLP-1 pill for weight loss?
Yes, two. Wegovy tablets (oral semaglutide) were added to the Wegovy label in December 2025, and the FDA approved Foundayo (orforglipron) on April 1, 2026. Both are taken once daily and both require a prescription.
How much weight did people lose on the Wegovy pill?
In Study 7 in the FDA label, adults with obesity or overweight and a weight-related condition lost an average of 13.6% of body weight over 64 weeks on Wegovy tablets, versus 2.4% on placebo (all randomized participants, 205 on the tablet and 102 on placebo). Results vary by person.
Which is cheaper, Wegovy tablets or Foundayo?
On November 11, 2026, NovoCare listed Wegovy tablets at $149 (1.5 mg), $199 (4 mg) and $299 (9 mg and 25 mg) a month, and LillyDirect listed Foundayo at $149 to $299 a month depending on dose. Both are self-pay prices that change, and some Foundayo prices are reduced only through December 31, 2026.
Do the pills have the same warnings as the injections?
The labels share the class boxed warning about thyroid C-cell tumors. Neither should be used by anyone with a personal or family history of medullary thyroid carcinoma or with MEN 2. Common side effects are mostly digestive: nausea, vomiting, diarrhea, constipation and stomach pain.
Can I take a GLP-1 pill and a GLP-1 injection together?
The labels say not to. Both the Wegovy and Foundayo information advise against combining with another GLP-1 receptor agonist. Your prescriber manages any switch between products.
Is Rybelsus the same as the Wegovy pill?
Both are oral semaglutide, but they are separate products with different labels. Rybelsus is approved for type 2 diabetes. Wegovy tablets are approved for weight management and cardiovascular risk reduction.